The News & Views article 'Cancer genomics: spot the difference' by Noah D. Peyser and Jennifer R. Grandis (Nature 541, 162–163; 2017) incorrectly stated that drugs that inhibit the activity of the protein KEAP1, which itself inhibits the transcription factor NRF2, could be used to combat activating mutations in the gene that encodes NRF2. Instead, it should have stated that this pathway could potentially be targeted for therapeutic use in certain oesophageal cancers if drugs are developed to inhibit mutant, activated NRF2.
Additional information
The online version of the original article can be found at 10.1038/nature21112
Rights and permissions
About this article
Cite this article
Correction. Nature 542, 42 (2017). https://doi.org/10.1038/542042a
Published:
Issue Date:
DOI: https://doi.org/10.1038/542042a
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
